Description

Leuprorelin SAN Doses 5 mg in Syringe №1

Ingredients:

Leuprorelin acetate is the active ingredient in Leuprorelin SAN 5 mg syringe. Other ingredients include mannitol, carboxymethylcellulose sodium, and acetic acid.

Dosage:

The recommended dose of Leuprorelin SAN 5 mg is administered as a subcutaneous injection once every month. The syringe is pre-filled for easy administration.

Indications:

Leuprorelin SAN 5 mg is indicated for the treatment of advanced prostate cancer, endometriosis, and central precocious puberty.

Contraindications:

Do not use Leuprorelin SAN 5 mg if you are allergic to leuprorelin or any of the other ingredients. It is contraindicated in pregnant women.

Directions:

Administer the injection subcutaneously into the abdomen, thigh, or buttocks. Follow the healthcare provider’s instructions for proper administration.

Scientific Evidence:

Studies have shown that Leuprorelin SAN 5 mg is effective in suppressing testosterone levels in prostate cancer patients, leading to tumor regression and improved survival rates. Research published in the Journal of Clinical Oncology demonstrated the efficacy of leuprorelin in advanced prostate cancer management.

Additional Information:

Leuprorelin acetate works by inhibiting the production of gonadotropin-releasing hormone, leading to decreased testosterone levels in males and estrogen levels in females. This hormonal suppression is beneficial in the treatment of hormone-sensitive conditions like prostate cancer and endometriosis.

Clinical trials have also shown the effectiveness of Leuprorelin SAN 5 mg in managing central precocious puberty by delaying the onset of puberty and improving adult height outcomes compared to untreated individuals. Consult your healthcare provider for more information on the benefits and potential side effects of Leuprorelin SAN 5 mg.